Articles

Review

Lymph Node Dissection for Differentiated Thyroid Cancer

Aviram Mizrachi
Ashok R. Shaha

Mol Imaging Radionucl Ther 2017; 26: 10-15 DOI: 10.4274/2017.26.suppl.02 PMID:28117285

Nuclear Medicine in Thyroid Diseases in Pediatric and Adolescent Patients

Bilge Volkan-Salancı
Pınar Özgen Kıratlı

Mol Imaging Radionucl Ther 2015; 24: 47-59 DOI: 10.4274/mirt.76476 PMID:26316469

Nuclear Molecular and Theranostic Imaging for Differentiated Thyroid Cancer

Arif Sheikh
Berna Polack
Yvette Rodriguez
Russ Kuker

Mol Imaging Radionucl Ther 2017; 26: 50-65 DOI: 10.4274/2017.26.suppl.06 PMID:28117289

Original Research

Prognostic Value of Basal Serum Thyroglobulin Levels, but Not Basal Antithyroglobulin Antibody (TgAb) Levels, in Patients with Differentiated Thyroid Cancer

Isa Neshandar Asli
Ali Shafiepour Siahkali
Babak Shafie
Hamid Javadi
Majid Assadi

Mol Imaging Radionucl Ther 2014; 23: 54-59 DOI: 10.4274/mirt.39200 PMID:24963446

Is Very High Thyroid Stimulating Hormone Level Required in Differentiated Thyroid Cancer for Ablation Success?

Zekiye Hasbek
Bülent Turgut

Mol Imaging Radionucl Ther 2016; 25: 79-84 DOI: 10.4274/mirt.88598 PMID:27277324

Recurrence Incidence in Differentiated Thyroid Cancers and the Importance of Diagnostic Iodine-131 Scintigraphy in Clinical Follow-up

Filiz Hatipoğlu
İnanç Karapolat
Özgür Ömür
Ayşegül Akgün
Ahmet Yanarateş
Kamil Kumanlıoğlu

Mol Imaging Radionucl Ther 2016; 25: 85-90 DOI: 10.4274/mirt.35220 PMID:27277325

The Evaluation of Microcarcinoma in Differentiated Thyroid Cancers According to Old and New TNM Classification

Zekiye Hasbek
Bülent Turgut
Taner Erselcan
Ayhan Koyuncu
Mehmet Fatih Börksüz
Nergiz Hacer Turgut
Fadime Yumuk

Mol Imaging Radionucl Ther 2011; 20: 94-99 DOI: 10.4274/MIRT.13 PMID:23486990

Case Report

I-131 Radiation-Induced Myelosuppression in Differentiated Thyroid Cancer Therapy

Stephan Probst
Gad Abikhzer
Guillaume Chaussé
Michael Tamilia

Mol Imaging Radionucl Ther 2018; 27: 84-87 DOI: 10.4274/mirt.59454 PMID:29889031

Original Articles

The Effects of the Factors Related to the Patient and the Disease on the Performance of Ablation Therapy in Patients with Differentiated Thyroid Cancer who have Received I-131 Ablation Therapy

Tarik Sengöz
Erdem Sürücü
Yusuf Demir
Erkan Derebek

Mol Imaging Radionucl Ther 2012; 21: 103-109 DOI: 10.4274/Mirt.25744 PMID:23487510

Original Article

Comparison of Radioactive Iodine Activities in Terms of Short- and Long-term Results in Ablation Therapy in Patients with Low-risk Differentiated Thyroid Cancer

Seray Saraçoğlu
Osman Güven
Gündüzalp Buğrahan Babacan
Savaş Karyağar
Tamer Özülker
Sadık Ergür
Sevda Sağlampınar Karyağar

Mol Imaging Radionucl Ther 2023; 32: 112-116 DOI: 10.4274/mirt.galenos.2022.05826 PMID:37337764

The Use of ¹⁸F-FDG PET/CT in Patients with Recurrent Differentiated Thyroid Cancer

Özgül Ekmekçioğlu

Mol Imaging Radionucl Ther 2021; 30: 137-143 DOI: 10.4274/mirt.galenos.2021.02360 PMID:34658228

1
2

About Journal

Forms

Useful Links

Latest Update: 16.04.2024